ES539290A0 - Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo - Google Patents

Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo

Info

Publication number
ES539290A0
ES539290A0 ES539290A ES539290A ES539290A0 ES 539290 A0 ES539290 A0 ES 539290A0 ES 539290 A ES539290 A ES 539290A ES 539290 A ES539290 A ES 539290A ES 539290 A0 ES539290 A0 ES 539290A0
Authority
ES
Spain
Prior art keywords
bifonazole
preparations
procedure
obtaining
active product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES539290A
Other languages
English (en)
Other versions
ES8601693A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES8601693A1 publication Critical patent/ES8601693A1/es
Publication of ES539290A0 publication Critical patent/ES539290A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES539290A 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo Granted ES539290A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833311701 DE3311701A1 (de) 1983-03-30 1983-03-30 Antimykotische mittel mit hoher wirkstoff-freisetzung in form von creme

Publications (2)

Publication Number Publication Date
ES8601693A1 ES8601693A1 (es) 1985-11-16
ES539290A0 true ES539290A0 (es) 1985-11-16

Family

ID=6195162

Family Applications (3)

Application Number Title Priority Date Filing Date
ES530846A Expired ES8503947A1 (es) 1983-03-30 1984-03-22 Agentes antimicoticos con elevada liberacion del producto activo
ES539289A Granted ES539289A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo
ES539290A Granted ES539290A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES530846A Expired ES8503947A1 (es) 1983-03-30 1984-03-22 Agentes antimicoticos con elevada liberacion del producto activo
ES539289A Granted ES539289A0 (es) 1983-03-30 1984-12-31 Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo

Country Status (19)

Country Link
JP (1) JPS59184106A (es)
KR (1) KR840008284A (es)
AU (1) AU564956B2 (es)
BE (1) BE899278A (es)
CA (1) CA1212327A (es)
CH (1) CH660126A5 (es)
CY (1) CY1358A (es)
DE (1) DE3311701A1 (es)
ES (3) ES8503947A1 (es)
FR (1) FR2543435B1 (es)
GB (1) GB2137091B (es)
GR (1) GR81485B (es)
IT (1) IT1173761B (es)
KE (1) KE3704A (es)
LU (1) LU85271A1 (es)
PH (1) PH20420A (es)
PT (1) PT78313B (es)
SE (1) SE8401748L (es)
ZA (1) ZA842337B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5087620A (en) * 1990-05-17 1992-02-11 Bristol-Myers Squibb Co. Controlled dermal penetration enhancement using imidazoles
ZA934007B (en) * 1992-06-08 1994-03-09 Schering Plough Healthcare Stable imidazole anti-fungal powder compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2461406C2 (de) * 1974-12-24 1984-06-14 Bayer Ag, 5090 Leverkusen Azolyl-(1)-methane und deren Salze, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DE3045914A1 (de) * 1980-12-05 1982-07-22 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045915A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung in form von elastischen fluessig-pflastern
DE3045913A1 (de) * 1980-12-05 1982-07-08 Bayer Ag, 5090 Leverkusen Antimykotische mittel mit hoher wirkstoff-freisetzung
DE3106635A1 (de) * 1981-02-23 1982-09-09 Bayer Ag Antimykotisches mittel mit hoher wirkstoff-freisetzung in form von stiften

Also Published As

Publication number Publication date
CY1358A (en) 1987-08-07
SE8401748L (sv) 1984-10-01
CA1212327A (en) 1986-10-07
IT1173761B (it) 1987-06-24
ES8601692A1 (es) 1985-11-16
GB8408067D0 (en) 1984-05-10
GR81485B (es) 1984-12-11
JPS59184106A (ja) 1984-10-19
DE3311701A1 (de) 1984-10-04
ES8601693A1 (es) 1985-11-16
SE8401748D0 (sv) 1984-03-29
CH660126A5 (de) 1987-03-31
BE899278A (fr) 1984-10-01
AU2623684A (en) 1984-10-04
PH20420A (en) 1987-01-05
FR2543435B1 (fr) 1988-06-17
PT78313A (en) 1984-04-01
ES530846A0 (es) 1985-04-16
KE3704A (en) 1987-03-27
IT8420303A0 (it) 1984-03-29
ZA842337B (en) 1984-11-28
PT78313B (en) 1986-06-02
GB2137091B (en) 1986-10-01
ES539289A0 (es) 1985-11-16
ES8503947A1 (es) 1985-04-16
LU85271A1 (de) 1984-11-14
KR840008284A (ko) 1984-12-14
GB2137091A (en) 1984-10-03
AU564956B2 (en) 1987-09-03
FR2543435A1 (fr) 1984-10-05

Similar Documents

Publication Publication Date Title
AR227814A1 (es) Procedimiento para la preparacion de un producto para evitar la caida del cabello y para fomentar su crecimiento
AR240791A1 (es) Procedimiento para la produccion de etileno y propileno.
NL7707897A (nl) Uit reeksen bestaande gepolyhydroxyleerde opper- vlak-aktieve oligomeren, en werkwijzen voor de bereiding van cosmetische preparaten.
IT8324122A0 (it) Derivati del7-carbossimetossifenilacetammido-3cefeme, procedimenti per la loro preparazione e preparazioni antibatteriche che li contengono.
AR227386A1 (es) Procedimiento para la preparacion de lh-rh o de analogos de lh-rh,con empleo de(glu-his(dnp)-oh
ES2018667B3 (es) Derivados del acido 4-qionolon-3-carboxilico, procedimiento para su obtencion y preparados farmaceuticos que los contienen.
BR8802557A (pt) Agente fisiologicamente ativo para uso agricola
IT1085949B (it) 2-benzil-pirrolidine,procedimento per la loro preparazione e prodotti medicinali che le contengono
MX11493A (es) Procedimiento para la preparacion de derivados de pirimidina y producto obtenido.
DE3378909D1 (en) Physiologically active substance p-23924, its production and use
ES534924A0 (es) Procedimiento para la obtencion de monoeteres alifaticos del 2,2-dimetilpropan-1,3-diol
ES493839A0 (es) Procedimiento para la obtencion de esteres del acido n-me- til-o-pirazol (4)il-carbamico,de efecto pesticida
ES539275A0 (es) Un procedimiento para la obtencion de derivados de bifanazol con elevada liberacion del producto activo
ES489185A0 (es) Un procedimiento para la preparacion de 1,1-dioxido de acidopenicilanico y esteres del mismo
ES539290A0 (es) Un procedimiento para la obtencion de preparados del bifonazol con elevada liberacion del producto activo
IT1194158B (it) Carbacicline,procedimento per la loro preparazione e loro impiego come medicinali
MX9200288A (es) Procedimiento para la preparacion del acido 1,2,3,4-tetrahidroisoquinolin-3-carboxilico racemico y opticamente activo asi como sus productos previos.
ES2018656B3 (es) Nuevos derivados del acido 16,17-acetal sustituido, procedimiento de preparacion del mismo y preparaciones farmaceuticas que los contienen.
ES542299A0 (es) Procedimiento para la preparacion de 1,3-bis-esteres fosfatoy esteres fosfato ciclico de 9-1,3-dihidroxi-2-propoximetil-guanina
IT8321573A0 (it) Procedimento per la preparazione del meta-clorobenzotrifluoruro.
IT1089233B (it) O-propilossime sostituite con sostituenti basici,procedimento per la loro preparazione e loro impiego come prodotti medicinali
MX159452A (es) Procedimiento para la preparacion del 8-metoxi-4,8-dimetil-1-(4-isopropilfenil)-no-nano
ES528109A0 (es) Procedimiento para la obtencion del 2,4,6 triyodofenol
ES518341A0 (es) Procedimiento para la preparacion del 7-metilo-3-metileno-7-octeno-1-ilo-propionato.
MX10085A (es) Procedimiento para la preparacion de 4-arilcarbonil-1-((4-morfolinil)-alquilo-inferior)-1h-indoles y producto obtenido.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20050723